Lilly’s Omvoh leads to 50% clinical remission rate in paediatric UC
Lilly said it will supply data to the FDA to support the label expansion of Omvoh in paediatric UC.
19 October 2026
19 October 2026
Lilly said it will supply data to the FDA to support the label expansion of Omvoh in paediatric UC.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.